Lana M. Chahine - Concepedia

Author

Lana M. Chahine

Also Known As

Andrew Siderowf, Chahine, Lana, Chahine, Lana M., Douglas Galasko, Ethan Brown, Joseph Jankovic, L Chahine, L M Chahine, L. Chahine, L. M. Chahine

250

Publications

Citations

H-Index

118

Concepts

All Affiliations

University of Pennsylvania University of Pittsburgh Michael J. Fox Foundation Institute for Neurodegenerative Disorders University of Iowa

About

Lana M. Chahine is an author at University of Pennsylvania specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.5K
2	Health Sciences	3	3	133
3	Public Health	3	3	43
4	Engineering	2	2	29
5	Nursing	2	2	48

Lana M. Chahine

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Annals of Clinical and Translational Neurology	2018	633
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, The Lancet Neurology Neurodegenerative DiseasesDisease ProgressionParkinson DiseaseNeurologyMedicine	2023	618
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease Daniel Weintraub, Tanya Simuni, Chelsea Caspell‐Garcia, Movement Disorders	2015	296
Longitudinal study of normal cognition in Parkinson disease Kara Pigott, Jacqueline Rick, Sharon X. Xie, Neurology	2015	252
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort Tanya Simuni, Andrew Siderowf, Shirley Lasch, Movement Disorders	2018	199
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression Brit Mollenhauer, Mohammed Dakna, Niels Kruse, Movement Disorders	2020	183
The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease Ethan Brown, Lana M. Chahine, Samuel M. Goldman, Journal of Parkinson s Disease	2020	177
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease Chelsea Caspell‐Garcia, Tanya Simuni, Duygu Tosun, PLoS ONE	2017	147
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease Lana M. Chahine, Thomas G. Beach, Michael C. Brumm, Neurology	2020	146
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, The Lancet Neurology Dopamine TransporterParkinson DiseaseNeuroscienceNeurologyDopamine	2019	135

Page 1